Azithromycin Improves Outcomes in Poorly Controlled Child Asthma

MONDAY, June 20, 2022 (HealthDay News) -- Azithromycin helps improve asthma control and reduce exacerbations in children with poorly controlled asthma, according to a study published in the June issue of CHEST.
Jagat Jeevan Ghimire, M.D., from All India Institute of Medical Sciences in New Delhi, and colleagues randomly assigned 120 children (5 to 15 years of age) with poorly controlled asthma to receive azithromycin three times weekly for three months along with standard treatment or standard treatment alone.
The researchers found that the numbers of children with well-controlled asthma according to Global Initiative for Asthma guidelines were 41 of 56 in the azithromycin group versus 10 of 56 in the control groups. The azithromycin group had a lower median number of exacerbations requiring emergency visit and steroid use (zero versus one). There was no difference observed between the groups for fractional exhaled nitric oxide level, spirometry parameters, positive throat swab results, or adverse effects.
"The beneficial effect of azithromycin was similar in children with eosinophilic versus noneosinophilic asthma and those 5 to 11 years of age and those 12 years of age or older," the authors write.
Abstract/Full Text (subscription or payment may be required)
Related Posts
FDA Issues Warning to Maker of Illegal Nicotine Gummies
FRIDAY, Aug. 19, 2022 (HealthDay News) – The U.S. Food and Drug Administration...
A Penicillin Allergy Is Bad News If You Get a Dental Implant
THURSDAY, April 14, 2022 (HealthDay News) -- While the vast majority of dental...
What Parents Need to Know About Cronobacter Bacteria in Baby Formula
WEDNESDAY, Oct. 26, 2022 (HealthDay News) -- Cronobacter sakazakii has been in...
Algorithm Predicts Urinary Tract Infection Without Microscopy
MONDAY, Jan. 23, 2023 (HealthDay News) -- The NoMicro classifier appears...